Zeniquin
زينيكوين
Zeniquin (marbofloxacin) is a potent synthetic broad-spectrum fluoroquinolone bactericidal antimicrobial for oral administration in dogs and cats. Indicated for the treatment of bacterial infections of the skin and soft tissue, urinary tract infections, and bacterial feline skin infections associated with susceptible organisms.
Dosage Form
Tablet
Product Type
Pharmaceutical
Manufacturer
Package
Bottles of 50 or 100 scored tablets (25 mg, 50 mg, 100 mg, and 200 mg)
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Dog | 2.75 to 5.5 mg marbofloxacin/kg body weight once daily | Oral (PO) | Once daily for 7 to 30 days depending on infection site and response |
| Cat | 2.75 to 5.5 mg marbofloxacin/kg body weight once daily | Oral (PO) | Once daily for up to 30 days |
Withdrawal Periods
No withdrawal information available.
Indications
-
Treatment of skin and soft tissue infections (wounds, abscesses, cellulitis) in dogs and cats caused by susceptible bacteria.
-
Treatment of urinary tract infections (cystitis) in dogs caused by susceptible strains of E. coli and Proteus mirabilis.
Contraindications
-
Do not use in immature, growing dogs (less than 12-18 months) due to potential cartilage erosion in weight-bearing joints.
-
Do not exceed recommended dose in cats due to risk of fluoroquinolone-induced retinopathy.
Precautions
-
Use with caution in animals with known Central Nervous System (CNS) disorders or epilepsy.
-
Ensure adequate hydration during treatment.
Side Effects
-
Mild gastrointestinal upset (decreased appetite, vomiting, soft stools); rare neurotoxicity or lethargy.
Images
Documents
-
Download
Zeniquin Prescribing Information
Leaflet
Active Ingredients
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.